Signaturefd, LLC Y M Abs Therapeutics, Inc. Transaction History

Signaturefd, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$11.6 - $17.25 $742 - $1,104	64 New	64 $0
Q3 2022 Nov 08, 2022	BUY	$13.96 - $19.67 $209 - $295	15 New	15 $0
Q2 2022 Aug 10, 2022	SELL	$8.22 - $15.13 $2,005 - $3,691	-244 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$6.55 - $17.42 $1,054 - $2,804	161 Added 193.98%	244 $3,000
Q4 2021 Jan 25, 2022	BUY	$15.51 - $29.31 $1,287 - $2,432	83 New	83 $1,000
Q3 2021 Oct 28, 2021	SELL	$27.47 - $37.31 $796 - $1,081	-29 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$25.45 - $37.64 $738 - $1,091	29 New	29 $1,000

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $356M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.